Protagonist Therapeutics, Inc Annual Return On Equity in % from 2017 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Protagonist Therapeutics, Inc quarterly/annual Return On Equity history and growth rate from 2017 to 2023.
  • Protagonist Therapeutics, Inc Return On Equity for the quarter ending September 30, 2024 was 34.7 %.
  • Protagonist Therapeutics, Inc annual Return On Equity for 2023 was -27.5 %, a 44.5% increase from 2022.
  • Protagonist Therapeutics, Inc annual Return On Equity for 2022 was -49.5 %, a 22.9% decline from 2021.
  • Protagonist Therapeutics, Inc annual Return On Equity for 2021 was -40.3 %, a 3.44% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -27.5 +22 +44.5% Jan 1, 2023 Dec 31, 2023
2022 -49.5 -9.23 -22.9% Jan 1, 2022 Dec 31, 2022
2021 -40.3 -1.34 -3.44% Jan 1, 2021 Dec 31, 2021
2020 -39 +46.7 +54.5% Jan 1, 2020 Dec 31, 2020
2019 -85.7 -51.7 -152% Jan 1, 2019 Dec 31, 2019
2018 -33.9 +13.1 +27.8% Jan 1, 2018 Dec 31, 2018
2017 -47 Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.